Risk factors and prognostic implications for pathologic upstaging to T3a after partial nephrectomy
Alp Tuna Beksaç(Cleveland Clinic), Ketan K. Badani(Henry Ford Health System), Ashok K. Hemal(Wake Forest University), James Porter(Swedish Medical Center), Alberto Martini(The University of Texas MD Anderson Cancer Center), David J. Paulucci(Mount Sinai Hospital), Akshay Bhandari(Mount Sinai Medical Center), Muthumeena Kannappan(Primary Health Care), Zeynep Gul(Zonguldak Bülent Ecevit University), Daniel Eun(Temple University Hospital), Ronney Abaza(OhioHealth), John P. Sfakianos(Mount Sinai Medical Center), Balaji Reddy(Icahn School of Medicine at Mount Sinai), Greg Gin(VA Long Beach Healthcare System)
Cited by 18
Related Papers
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|656
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
|Annals of the Rheumatic Diseases|2001|287
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines
|European Urology|2025|190